---
title: Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients
  With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After
  EGFR Inhibition
date: '2024-08-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39153867/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240818182213&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: In this real-world study, EGFRi/METi showed clinical benefit
  over METi and SoC. Future studies should focus on the differential impact of the
  type of MET CNG with a focus on true MET amplification as predictor of ...'
disable_comments: true
---
CONCLUSION: In this real-world study, EGFRi/METi showed clinical benefit over METi and SoC. Future studies should focus on the differential impact of the type of MET CNG with a focus on true MET amplification as predictor of ...